RYAM President & CEO to present at Gabelli Funds 14th Annual Specialty Chemicals Symposium
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Rayonier Advanced Materials (NYSE:RYAM) announced that President and CEO Lyle W. Bloomquist will present at the Gabelli Funds 14th Annual Specialty Chemicals Symposium on Thursday, March 16, 2023, at 1:00 PM ET. RYAM is a leader in cellulose-based technologies, focusing on high purity cellulose specialties used in various industries including food and pharmaceuticals. The company operates in the U.S., Canada, and France, employs over 2,500 individuals, and generated approximately $1.7 billion in revenue in 2022. For further details, visit www.RYAM.com.
Positive
None.
Negative
None.
Insights
Analyzing...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--
Rayonier Advanced Materials Inc. (NYSE:RYAM) announced today De Lyle W. Bloomquist, President and CEO, will be presenting at the Gabelli Funds 14th Annual Specialty Chemicals Symposium on Thursday, March 16, 2023, at 1:00 PM ET.
About RYAM
RYAM is a global leader of cellulose-based technologies, including high purity cellulose specialties, a natural polymer commonly found in filters, food, pharmaceuticals and other industrial applications. The Company also manufactures products for paper and packaging markets. With manufacturing operations in the U.S., Canada and France, RYAM employs just over 2,500 people and generated an estimated $1.7 billion of revenues in 2022. More information is available at www.RYAM.com.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.